Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04756427 · ClinicalTrials.gov registry record · Phase 4
Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition
A Phase 4 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT04756427: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.
NCT04756427 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04756427, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study an open label prospective observational cohort study to evaluate the safety and efficacy of sodium citrate 4% locking solution in preventing central line associated blood stream infection in children requiring long term central venous catheters for home parenteral nutrition. Sodium citrate 4% is FDA-approved for dialysis catheters, but has not been formally evaluated for use in tunneled catheters for parenteral nutrition. The rate of central line-associated bloodstream infection (CLABSI) and other potential adverse events will be monitored for 12 months, with the option to remain in the study for a longer period of time.
Interventions
- DRUG Sodium Citrate 4% Inj Syringe 3Ml
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2023-11-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04756427
The ClinicalTrials.gov registry entry for NCT04756427 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sodium Citrate 4% Inj Syringe 3Ml is the first listed.
NCT04756427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04756427 about?
NCT04756427 is a clinical study titled "Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition". This study an open label prospective observational cohort study to evaluate the safety and efficacy of sodium citrate 4% locking solution in preventing central line associated blood stream infection in children requiring long term central venous catheters for home parenteral nutrition. Sodium citrat...
What is the current status of trial NCT04756427?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2022-03-28. Estimated completion is 2023-11-28.
What interventions are being tested in trial NCT04756427?
The interventions under investigation include: Sodium Citrate 4% Inj Syringe 3Ml (DRUG).
Who is sponsoring clinical trial NCT04756427?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.